ClearView Wealth Board Approves $0.05 Fully Franked Special Dividend Ahead of Zurich Acquisition Vote

Details of ClearView’s Special Dividend and Franking Credit Advantages

ClearView Wealth has announced a fully franked Special Dividend of $0.05 per share, payable if the Zurich acquisition scheme is implemented. This dividend is permitted by the scheme implementation deed agreed with Zurich, initially announced in February 2026. It represents a capital return to shareholders ahead of the proposed acquisition’s completion, enabling the company to allocate surplus capital before finalizing the transaction.

The attached franking credits enhance value for eligible shareholders. The company states some shareholders could realize up to $0.0214 per share in franking credits. When combined with the adjusted Scheme Consideration of $0.60 per share and the $0.05 dividend, this equates to approximately $0.67 per share in total value. However, the actual benefit depends on individual tax circumstances, making professional tax advice essential for shareholders evaluating the transaction.

Scheme Consideration Reduction and Overall Shareholder Value

Paying the Special Dividend triggers a reduction in the Scheme Consideration from $0.65 to $0.60 per share, as outlined in the scheme implementation deed. This adjustment aligns the total capital returned to shareholders with the dividend payment, preserving the agreed transaction economics. The structure accommodates shareholder distributions between announcement and implementation phases.

Shareholders assessing the total economic impact should consider the $0.60 Scheme Consideration, the $0.05 Special Dividend, and potential franking credits up to $0.0214 per share. ClearView emphasizes that tax outcomes will vary significantly based on each shareholder’s marginal tax rate, ability to utilize franking credits, and residency status. To clarify tax treatment, the company has applied for an Australian Taxation Office (ATO) Class Ruling, expected after scheme implementation.

ATO Class Ruling Application to Clarify Tax Treatment

ClearView has requested a Class Ruling from the Australian Taxation Office to confirm the tax implications of the Scheme and Special Dividend for eligible shareholders. The ruling will address franking credit integrity rules and income tax consequences. The company expects the ruling to be issued post-scheme effectiveness and does not anticipate deviations from the positions outlined in the application and Scheme Booklet.

The Class Ruling is vital for shareholder confidence regarding tax treatment. Section 10 of the Scheme Booklet summarizes Australian tax consequences, but ClearView advises all shareholders to seek independent professional tax advice before making decisions. The final ruling will be publicly available on the ATO website, providing definitive guidance on franking credit treatment under Australian law. This phased approach—pre-vote guidance and post-implementation ruling—reflects the complexity of franking credit regulations in this transaction.

Shareholder Scheme Meeting Scheduled for 27 July 2026

Shareholders will vote on the Scheme at a hybrid meeting on Monday, 27 July 2026, at 10:00am Sydney time. The meeting will decide whether to approve Zurich’s acquisition at the adjusted $0.60 per share consideration, with the $0.05 Special Dividend payable if the scheme proceeds. Proxy appointments must be lodged by 10:00am Sydney time on Saturday, 25 July 2026, via methods detailed in the Scheme Booklet or online at www.investorvote.com.au.

The Scheme Booklet, distributed on 26 June 2026, provides detailed transaction information, including voting procedures, proxy appointments, and tax implications. ClearView directors unanimously recommend voting in favor of the Scheme, contingent on continued Independent Expert support and absence of a Superior Proposal. Directors holding shares intend to vote in favor, signaling board alignment with the transaction and dividend decision.

Crescent Capital Partners’ Voting Intent and Support

Crescent Capital Partners, ClearView’s largest shareholder with 53.0% ownership as of the announcement date, has communicated its intention to vote all shares in favor of the Scheme. This substantial pre-commitment endorses the acquisition by Zurich. Crescent’s support is conditional on the ClearView Board’s unanimous recommendation, ongoing Independent Expert endorsement, no Superior Proposal arising, and implementation by 24 February 2027.

Control of over half the shares by Crescent significantly enhances the likelihood of Scheme approval at the shareholder meeting. Their conditional commitment indicates acceptance of the transaction terms, including the Special Dividend and adjusted Scheme Consideration. The 24 February 2027 implementation deadline sets a clear timeframe roughly one year from the initial announcement.

ClearView’s Business Overview and Market Standing

ClearView Wealth Limited operates within the Australian financial services sector and is currently subject to Zurich Financial Services Australia Limited’s proposed acquisition. The company’s financial position supports a fully franked Special Dividend of $0.05 per share, reflecting prior profitability and cash generation. The fully franked nature of the dividend indicates sufficient franking credits from previous Australian tax payments.

While specific revenue and profit figures are not disclosed, the dividend capacity suggests solid operational performance before the scheme announcement. Zurich’s interest as a major international financial services provider implies ClearView holds valuable market presence, client relationships, or operational strengths of strategic importance.

Scheme Implementation Timeline and Conditions for Effectiveness

The Special Dividend Record Date is expected at 7:00pm Sydney time on Wednesday, 5 August 2026, with payment anticipated on Wednesday, 12 August 2026, contingent on the Scheme becoming effective. This requires completion of all regulatory approvals and shareholder votes prior to dividend payment. The brief interval between the 27 July 2026 Scheme Meeting and the 5 August Record Date reflects an expedited schedule.

Dividend payment is conditional on Scheme effectiveness, meaning shareholders cannot rely on receiving the $0.05 dividend until all conditions precedent, including ASIC approval and regulatory consents, are satisfied. Although the announcement does not specify the status of these approvals, the timeline indicates ClearView expects the Scheme to be effective within two weeks of the shareholder vote.

Risks Related to Franking Credits and Scheme Completion

A key risk is that franking credit benefits depend on individual tax circumstances and are not assured for all shareholders. The company notes that the potential $0.0214 franking credit applies only to certain shareholders, influenced by marginal tax rates, franking credit utilization, and residency. Shareholders such as pension funds, non-residents, or those lacking sufficient tax liabilities may receive no franking benefit, resulting in varied economic outcomes from the same $0.05 dividend.

Another risk is the reliance on the Scheme becoming effective. Failure to secure shareholder approval, Independent Expert support, or regulatory consent would mean the Special Dividend is not paid. Shareholders voting in favor expecting the dividend would miss out if the transaction does not proceed. Additionally, the ATO Class Ruling, expected post-implementation, could theoretically differ from current positions, potentially causing tax surprises. ClearView advises all shareholders to seek independent tax advice due to these complexities.

Independent Expert Review and Shareholder Governance

The ClearView Board’s recommendation to support the Scheme is conditional on the Independent Expert maintaining the view that the Scheme is in shareholders’ best interests. This condition underscores the importance of the Independent Expert’s assessment as a governance safeguard. The Scheme Booklet, issued on 26 June 2026, includes the Independent Expert’s analysis but notes this may be updated if new material information arises before the 27 July 2026 meeting.

The governance framework also includes a Superior Proposal clause, allowing the Board to recommend a better offer if one emerges. The recommendation "in the absence of a Superior Proposal" indicates the $0.60 Scheme Consideration plus $0.05 dividend is not final if a superior bid is received. This aligns with standard takeover practices and assures shareholders that the Board can respond to improved offers. The continued unanimous Board support and Crescent Capital Partners’ backing suggest the current deal is unlikely to be replaced.